{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:43:43Z","timestamp":1792665823825,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T10:20:40Z","timestamp":1472811640000},"page":"63-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase"],"prefix":"10.1016","volume":"134","author":[{"given":"Rachel","family":"Fearns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Deval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.006_bib1","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","article-title":"Taxonomy of the order Mononegavirales: update 2016","volume":"161","author":"Afonso","year":"2016","journal-title":"Arch. Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2016.08.006_bib2","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1128\/JVI.02349-15","article-title":"Investigating the influence of ribavirin on human respiratory syncytial virus RNA synthesis using a high-resolution RNAseq approach","volume":"90","author":"Aljabr","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2003.07.004","article-title":"Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus","volume":"60","author":"Andries","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib4","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1099\/vir.0.053025-0","article-title":"The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid","volume":"94","author":"Bakker","year":"2013","journal-title":"J.\u00a0Gen. Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2016.08.006_bib5","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in\u00a0Vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib6","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1128\/JVI.66.11.6813-6818.1992","article-title":"Transcription of human respiratory syncytial virus genome RNA in\u00a0vitro: requirement of cellular factor(s)","volume":"66","author":"Barik","year":"1992","journal-title":"J.\u00a0Virol."},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2016.08.006_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1099\/0022-1317-74-3-485","article-title":"The structure of the 5\u2032 terminal cap of the respiratory syncytial virus mRNA","volume":"74","author":"Barik","year":"1993","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","article-title":"Molecular mechanism of respiratory syncytial virus fusion inhibitors","volume":"12","author":"Battles","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib9","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1128\/JVI.03086-12","article-title":"The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism","volume":"87","author":"Baviskar","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib10","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.96.20.11259","article-title":"The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription","volume":"96","author":"Bermingham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1021\/jm701284j","article-title":"Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121)","volume":"51","author":"Bonfanti","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib12","first-page":"862","article-title":"Drugs for the management of respiratory syncytial virus infection","volume":"5","author":"Broughton","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.antiviral.2016.08.006_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/protein\/15.2.101","article-title":"In silico identification, structure prediction and phylogenetic analysis of the 2\u2032-O-ribose (cap 1) methyltransferase domain in the large structural protein of ssRNA negative-strand viruses","volume":"15","author":"Bujnicki","year":"2002","journal-title":"Protein Eng."},{"key":"10.1016\/j.antiviral.2016.08.006_bib14","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.febslet.2010.05.006","article-title":"Direct visualization of the small hydrophobic protein of human respiratory syncytial virus reveals the structural basis for membrane permeability","volume":"584","author":"Carter","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2016.08.006_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.04119-14","article-title":"Mechanism of action for respiratory syncytial virus inhibitor RSV604","volume":"59","author":"Challa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib16","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib17","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1128\/AAC.48.7.2448-2454.2004","article-title":"Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection","volume":"48","author":"Cianci","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib18","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.bmcl.2015.04.073","article-title":"Discovery of beta-D-2\u2032-deoxy-2\u2032-alpha-fluoro-4\u2032-alpha-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases","volume":"25","author":"Clarke","year":"2015","journal-title":"Bioorg Med. Chem. Lett."},{"issue":"Pt 12","key":"10.1016\/j.antiviral.2016.08.006_bib19","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1099\/0022-1317-72-12-3095","article-title":"Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus","volume":"72","author":"Collins","year":"1991","journal-title":"J.\u00a0Gen. Virol."},{"issue":"Pt 4","key":"10.1016\/j.antiviral.2016.08.006_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1099\/0022-1317-73-4-849","article-title":"Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A","volume":"73","author":"Collins","year":"1992","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib21","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1073\/pnas.80.11.3208","article-title":"cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus","volume":"80","author":"Collins","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/JVI.49.2.572-578.1984","article-title":"Identification of a tenth mRNA of respiratory syncytial virus and assignment of polypeptides to the 10 viral genes","volume":"49","author":"Collins","year":"1984","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib23","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1073\/pnas.83.13.4594","article-title":"Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order","volume":"83","author":"Collins","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib24","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1073\/pnas.88.21.9663","article-title":"Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene","volume":"88","author":"Collins","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib25","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.92.25.11563","volume":"92","author":"Collins","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.93.1.81","article-title":"Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus","volume":"93","author":"Collins","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib27","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib28","doi-asserted-by":"crossref","first-page":"11311","DOI":"10.1128\/JVI.79.17.11311-11322.2005","article-title":"Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3\u2032 end of the nucleocapsid and can scan to access internal signals","volume":"79","author":"Cowton","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijantimicag.2014.12.025","article-title":"Chemotherapy of respiratory syncytial virus infections: the final breakthrough","volume":"45","author":"De Clercq","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.antiviral.2016.08.006_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2675","article-title":"Conventional and unconventional mechanisms for capping viral mRNA","volume":"10","author":"Decroly","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib31","doi-asserted-by":"crossref","first-page":"e1004995","DOI":"10.1371\/journal.ppat.1004995","article-title":"Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2\u2032-fluoro-4\u2032-chloromethyl-cytidine triphosphate","volume":"11","author":"Deval","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.08.006_bib32","doi-asserted-by":"crossref","first-page":"e0154097","DOI":"10.1371\/journal.pone.0154097","article-title":"Biochemical effect of resistance mutations against synergistic inhibitors of RSV RNA polymerase","volume":"11","author":"Deval","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.006_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3851\/IMP2064","article-title":"The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses","volume":"17","author":"DeVincenzo","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.08.006_bib34","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.08.006_bib35","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"DeVincenzo","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.08.006_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/JVI.52.2.364-369.1984","article-title":"Transcriptional mapping of human respiratory syncytial virus","volume":"52","author":"Dickens","year":"1984","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib37","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/JVI.77.9.5054-5064.2003","article-title":"Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein","volume":"77","author":"Douglas","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.03.015","article-title":"Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen","volume":"131","author":"Duvall","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","article-title":"Respiratory syncytial virus infection in elderly adults","volume":"22","author":"Falsey","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.antiviral.2016.08.006_bib40","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.08.006_bib41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/JVI.73.1.388-397.1999","article-title":"Model for polymerase access to the overlapped L gene of respiratory syncytial virus","volume":"73","author":"Fearns","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib42","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1128\/JVI.73.7.5852-5864.1999","article-title":"Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription","volume":"73","author":"Fearns","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/viro.1997.8734","article-title":"Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome","volume":"236","author":"Fearns","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib44","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1128\/JVI.76.4.1663-1672.2002","article-title":"Mapping the transcription and replication promoters of respiratory syncytial virus","volume":"76","author":"Fearns","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib48","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.1128\/JVI.01225-08","article-title":"S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein","volume":"82","author":"Galloway","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.virol.2008.08.041","article-title":"Analysis of a structural homology model of the 2'-O-ribose methyltransferase domain within the vesicular stomatitis virus L protein","volume":"382","author":"Galloway","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1110\/ps.073366208","article-title":"Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain","volume":"17","author":"Gan","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2016.08.006_bib51","doi-asserted-by":"crossref","first-page":"24671","DOI":"10.1074\/jbc.M111.332791","article-title":"The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels","volume":"287","author":"Gan","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/viro.1993.1366","article-title":"Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein","volume":"195","author":"Garcia","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib53","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1099\/0022-1317-83-4-753","article-title":"Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells","volume":"83","author":"Ghildyal","year":"2002","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib54","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1128\/JVI.69.9.5677-5686.1995","article-title":"RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA","volume":"69","author":"Grosfeld","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/JVI.75.1.36-44.2001","article-title":"RNA sequences involved in transcriptional termination of respiratory syncytial virus","volume":"75","author":"Harmon","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib56","doi-asserted-by":"crossref","first-page":"571609","DOI":"10.1155\/2014\/571609","article-title":"Effectiveness of palivizumab in preventing RSV hospitalization in high risk children: a real-world perspective","volume":"2014","author":"Homaira","year":"2014","journal-title":"Int. J. Pediatr."},{"key":"10.1016\/j.antiviral.2016.08.006_bib57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.virol.2015.01.019","article-title":"Innate immune restriction and antagonism of viral RNA lacking 2-O methylation","volume":"479\u2013480","author":"Hyde","year":"2015","journal-title":"Virology"},{"issue":"10043","key":"10.1016\/j.antiviral.2016.08.006_bib58","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(16)30386-5","article-title":"Late Ebola virus relapse causing meningoencephalitis: a case report","volume":"388","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.08.006_bib59","doi-asserted-by":"crossref","first-page":"e68347","DOI":"10.1371\/journal.pone.0068347","article-title":"The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5\u2032-triphosphate towards influenza A virus polymerase","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.08.006_bib60","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1128\/AAC.01391-15","article-title":"Biochemical evaluation of the inhibition properties of Favipiravir and 2\u2032-C-methyl-cytidine triphosphates against human and mouse norovirus RNA polymerases","volume":"59","author":"Jin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib61","doi-asserted-by":"crossref","first-page":"e1005318","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures","volume":"11","author":"Johnson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.08.006_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/scitranslmed.3008517","article-title":"An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model","volume":"6","author":"Krumm","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2016.08.006_bib63","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1128\/JVI.70.10.6892-6901.1996","article-title":"Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus","volume":"70","author":"Kuo","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib64","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1128\/JVI.71.7.4944-4953.1997","article-title":"Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA","volume":"71","author":"Kuo","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib65","first-page":"71","article-title":"Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen","volume":"115C","author":"Laganas","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib66","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.1128\/JVI.79.21.13373-13384.2005","article-title":"Amino acid residues within conserved domain VI of the vesicular stomatitis virus large polymerase protein essential for mRNA cap methyltransferase activity","volume":"79","author":"Li","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib67","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1073\/pnas.0509821103","article-title":"A\u00a0unique strategy for mRNA cap methylation used by vesicular stomatitis virus","volume":"103","author":"Li","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/JVI.02107-07","article-title":"A\u00a0conserved motif in region v of the large polymerase proteins of nonsegmented negative-sense RNA viruses that is essential for mRNA capping","volume":"82","author":"Li","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib69","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1128\/JVI.02162-08","article-title":"Opposing effects of inhibiting cap addition and cap methylation on polyadenylation during vesicular stomatitis virus mRNA synthesis","volume":"83","author":"Li","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib70","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cell.2015.06.018","article-title":"Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy","volume":"162","author":"Liang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2016.08.006_bib71","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1128\/JVI.79.20.13105-13115.2005","article-title":"Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase","volume":"79","author":"Liuzzi","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib72","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0021-9258(17)40638-7","article-title":"Relative importance of 7-methylguanosine in ribosome binding and translation of vesicular stomatitis virus mRNA in wheat germ and reticulocyte cell-free systems","volume":"252","author":"Lodish","year":"1977","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib73","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/jm5017768","article-title":"Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study","volume":"58","author":"Mackman","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib74","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1128\/JVI.00526-07","article-title":"The 24-angstrom structure of respiratory syncytial virus nucleocapsid protein-RNA decameric rings","volume":"81","author":"Maclellan","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib75","first-page":"93","article-title":"Analysis of the mutations in the active site of the RNA-dependent RNA polymerase of human parainfluenza virus type 3 (HPIV3)","volume":"10","author":"Malur","year":"2002","journal-title":"Gene Expr."},{"key":"10.1016\/j.antiviral.2016.08.006_bib76","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1128\/JVI.77.19.10670-10676.2003","article-title":"Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity","volume":"77","author":"Mason","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib77","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1093\/nar\/gkh809","article-title":"Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor","volume":"32","author":"Mason","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/viro.1994.1624","article-title":"Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants","volume":"205","author":"Mazumder","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib79","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JVI.02417-15","article-title":"The interferon type I\/III response to respiratory syncytial virus infection in airway epithelial cells can be attenuated or amplified by antiviral treatment","volume":"90","author":"McCutcheon","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib80","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JVI.79.4.2449-2460.2005","article-title":"Identification of internal sequences in the 3\u2032 leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity","volume":"79","author":"McGivern","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib81","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virusres.2015.02.024","article-title":"The Pneumovirinae fusion (F) protein: a common target for vaccines and antivirals","volume":"209","author":"Melero","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib82","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0042-6822(91)90532-G","article-title":"Nucleotide sequences of the 3\u2032 leader and 5\u2032 trailer regions of human respiratory syncytial virus genomic RNA","volume":"185","author":"Mink","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib83","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/JVI.06744-11","article-title":"The human respiratory syncytial virus matrix protein is required for maturation of viral filaments","volume":"86","author":"Mitra","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib84","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/emboj.2011.483","article-title":"Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase","volume":"31","author":"Morin","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2016.08.006_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0042-6822(02)00063-6","article-title":"Investigations into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein","volume":"307","author":"Murphy","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.08.006_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/255033a0","article-title":"5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation","volume":"255","author":"Muthukrishnan","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.006_bib87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.08.006_bib88","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/jm201699w","article-title":"Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics","volume":"55","author":"Ndungu","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib89","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/nar\/gkv1286","article-title":"Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation","volume":"44","author":"Neubauer","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib90","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1261\/rna.2813411","article-title":"The first two nucleotides of the respiratory syncytial virus antigenome RNA replication product can be selected independently of the promoter terminus","volume":"17","author":"Noton","year":"2011","journal-title":"RNA"},{"key":"10.1016\/j.antiviral.2016.08.006_bib91","doi-asserted-by":"crossref","first-page":"10226","DOI":"10.1073\/pnas.0913065107","article-title":"Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion","volume":"107","author":"Noton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib92","doi-asserted-by":"crossref","first-page":"e1002980","DOI":"10.1371\/journal.ppat.1002980","article-title":"The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoter","volume":"8","author":"Noton","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.08.006_bib93","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1128\/JVI.00530-15","article-title":"Respiratory syncytial virus inhibitor AZ-27 differentially inhibits different polymerase activities at the promoter","volume":"89","author":"Noton","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib95","doi-asserted-by":"crossref","first-page":"12112","DOI":"10.1093\/nar\/gku901","article-title":"Capping of vesicular stomatitis virus pre-mRNA is required for accurate selection of transcription stop-start sites and virus propagation","volume":"42","author":"Ogino","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molcel.2006.11.013","article-title":"Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus","volume":"25","author":"Ogino","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2016.08.006_bib97","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1099\/vir.0.019307-0","article-title":"The HR motif in the RNA-dependent RNA polymerase L protein of Chandipura virus is required for unconventional mRNA-capping activity","volume":"91","author":"Ogino","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib98","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1074\/jbc.M411167200","article-title":"Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA","volume":"280","author":"Ogino","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib99","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/JVI.63.5.2019-2029.1989","article-title":"The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species","volume":"63","author":"Olmsted","year":"1989","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib100","doi-asserted-by":"crossref","first-page":"11129","DOI":"10.1128\/JVI.01612-15","article-title":"A\u00a0druggable pocket at the nucleocapsid\/phosphoprotein interaction site of human respiratory syncytial virus","volume":"89","author":"Ouizougun-Oubari","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib101","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1038\/ncomms9749","article-title":"X-ray structure and activities of an essential Mononegavirales L-protein domain","volume":"6","author":"Paesen","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2016.08.006_bib102","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.74.1.146-155.2000","article-title":"Mutations in the 5' trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step","volume":"74","author":"Peeples","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib103","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","article-title":"Identification of four conserved motifs among the RNA-dependent polymerase encoding elements","volume":"8","author":"Poch","year":"1989","journal-title":"Embo J."},{"issue":"Pt 5","key":"10.1016\/j.antiviral.2016.08.006_bib104","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1099\/0022-1317-71-5-1153","article-title":"Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains","volume":"71","author":"Poch","year":"1990","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib105","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1073\/pnas.0401449101","article-title":"Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA","volume":"101","author":"Qanungo","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib106","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1128\/JVI.01426-09","article-title":"Ribose 2\u2032-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein","volume":"83","author":"Rahmeh","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib107","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12627","article-title":"Nucleocapsid assembly in pneumoviruses is regulated by conformational switching of the N protein","volume":"5","author":"Renner","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2016.08.006_bib108","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1128\/JVI.21.2.683-693.1977","article-title":"Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in\u00a0vitro in the presence of S-adenosylhomocysteine","volume":"21","author":"Rose","year":"1977","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib109","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4155\/fmc.10.235","article-title":"Respiratory syncytial virus: a prioritized or neglected target?","volume":"2","author":"Roymans","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib110","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1128\/AAC.00761-15","article-title":"GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein","volume":"59","author":"Samuel","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-5-69","article-title":"Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters","volume":"5","author":"Schickli","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2016.08.006_bib112","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with Favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2016.08.006_bib113","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/JVI.67.3.1334-1339.1993","article-title":"Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase","volume":"67","author":"Sleat","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib114","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1021\/jm801595c","article-title":"The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4\u2032-azidocytidine against hepatitis C virus replication: the discovery of 4\u2032-azido-2\u2032-deoxy-2\u2032-fluorocytidine and 4\u2032-azido-2\u2032-dideoxy-2\u2032,2\u2032-difluorocytidine","volume":"52","author":"Smith","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib116","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1128\/JVI.73.9.7199-7209.1999","article-title":"Transcript initiation and 5\u2032-end modifications are separable events during vesicular stomatitis virus transcription","volume":"73","author":"Stillman","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib117","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2004.12.002","article-title":"YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action","volume":"65","author":"Sudo","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.006_bib118","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1021\/jm701239a","article-title":"Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex","volume":"51","author":"Sun","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib119","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.1317262111","article-title":"Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation","volume":"111","author":"Tanner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.08.006_bib120","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1126\/science.1177634","article-title":"Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus","volume":"326","author":"Tawar","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.08.006_bib121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187152612800100170","article-title":"The non-structural proteins of RSV: targeting interferon antagonists for vaccine development","volume":"12","author":"Teng","year":"2012","journal-title":"Infect. Disord. Drug Targets"},{"key":"10.1016\/j.antiviral.2016.08.006_bib122","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2016.08.006_bib123","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1128\/AAC.02540-14","article-title":"Characterization of a respiratory syncytial virus L protein inhibitor","volume":"58","author":"Tiong-Yip","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib124","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.02862-12","article-title":"Respiratory syncytial virus polymerase can initiate transcription from position 3 of the leader promoter","volume":"87","author":"Tremaglio","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib125","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1128\/JVI.01057-07","article-title":"Vesicular stomatitis virus mRNA capping machinery requires specific cis-acting signals in the RNA","volume":"81","author":"Wang","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib126","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/jm5017279","article-title":"Discovery of 4\u2032-chloromethyl-2\u2032-deoxy-3\u2032,5\u2032-di-O-isobutyryl-2\u2032-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection","volume":"58","author":"Wang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.006_bib127","series-title":"Nucleotide Prodrug GS-5734 Is a Broad-spectrum Filovirus Inhibitor that Provides Complete Therapeutic Protection against the Development of Ebola Virus Disease (EVD) in Infected Non-human Primates","author":"Warren","year":"2015"},{"key":"10.1016\/j.antiviral.2016.08.006_bib128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.006_bib129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.08.006_bib130","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00289-07","article-title":"Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity","volume":"51","author":"White","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"24","key":"10.1016\/j.antiviral.2016.08.006_bib131","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1016\/j.bmcl.2013.10.018","article-title":"Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor","volume":"23","author":"Xiong","year":"2013","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.08.006_bib132","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/AAC.00503-09","article-title":"Target analysis of the experimental measles therapeutic AS-136A","volume":"53","author":"Yoon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.006_bib133","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1128\/JVI.69.4.2412-2419.1995","article-title":"Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication","volume":"69","author":"Yu","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.006_bib134","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1017\/S095026880600776X","article-title":"The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus","volume":"135","author":"Yusuf","year":"2007","journal-title":"Epidemiol. Infect."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T16:04:18Z","timestamp":1657209858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":134,"alternative-id":["S0166354216303527"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}